基于细胞膜的纳米纤维作为动脉样硬化治疗的潜在药物输送系统
Osvaldo Beltrán1, Alba Costa-Santos1, Mariangel Luna1
1Colloids and Polymers Physics Group, Particle Physics Department, Materials Institute (iMATUS), Health Research Institute (IDIS), University of Santiago de Compostela, Spain.
Colloids and surfaces. B, Biointerfaces
|October 17, 2025
概括
装有普拉瓦斯塔丁的生物仿真纳米微粒显示为动脉样硬化治疗的前景. 这些新型药物载体向炎症血管,减少炎症,促进胆固醇释放,为系统性他类药物治疗提供更安全的替代方案.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化是导致死亡的主要原因,源于内皮功能障碍和斑块发育.
- 目前的他类药物治疗有系统性的副作用,需要有针对性的药物输送系统.
- 生物仿真纳米微粒 (NVs) 提供生物相容性,免疫逃避和药物输送的自然向.
研究的目的:
- 开发和描述来自巨细胞膜的普拉斯塔丁载荷纳米纤维 (PRA载荷NVs).
- 评估这些NVs在动脉样硬化治疗中的治疗潜力.
主要方法:
- 从RAW 264.7巨细胞膜制造PRA装载NV的制造和特征.
- 评估NV整合素受体表达 (CD49d,CD11b) 针对炎症内皮的向.
- 在体外对药物封装,持续释放,生物相容性,细胞吸收和治疗疗效的评估.
主要成果:
- 带有PRA的NV保留了整合素受体,这表明潜在的向是炎症血管 (VCAM,ICAM-I).
- 这些NV显示了有效的封装,持续的普拉瓦斯塔丁释放,高生物相容性和细胞吸收.
- 功能性测试证实了普拉瓦斯塔丁的治疗效果:减少了促炎性细胞因子,促进了泡细胞胆固醇的释放.
结论:
- 仿生NV是动脉样硬化的有效药物载体,保持治疗性载荷活动.
- 与系统性他类药物相比,这些NV显示出有针对性输送,增强疗效和减少副作用的潜力.
- 这项研究强调了巨细胞衍生的NVs作为动脉样硬化治疗的创新治疗剂的前景.
相关概念视频
Receptor-mediated Endocytosis
110.5K
Overview
110.5K
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Bioavailability Enhancement: Drug Permeability Enhancement
184
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
184


